Literature DB >> 8025232

Tubular cell protein degradation in early diabetic renal hypertrophy.

P Shechter1, G Boner, R Rabkin.   

Abstract

Renal hypertrophy in diabetes is accompanied by an increase in kidney protein content, which reflects an imbalance between protein synthesis and degradation. This study determines whether altered cellular protein degradation contributes to the imbalance. Diabetes was induced in rats with streptozotocin (55 mg/kg/ip). After 2 or 4 days of diabetes, kidney weight and protein content were measured. Over the 4 days, despite a loss in body weight, kidney wet weight increased by 35% and protein content by 37% in the diabetic rats. Treatment with insulin prevented this increase. Long-lived protein degradation was measured in isolated proximal tubules prelabeled with (14C)valine in vivo. Two days after streptozotocin, protein degradation was depressed by 19% (P < 0.05) and by the fourth day by 27% compared with that in nondiabetic controls (2.6% +/- 0.2 versus 1.9 +/- 0.1% degraded/h; P < 0.01). This was accompanied by a similar diabetes-induced decrease in proximal tubule cathepsin B and L activity. Accordingly, this study provides direct evidence that, in diabetes, tubular cell protein breakdown is depressed and suggests that altered lysosomal cathepsin activity may contribute to this effect. Depressed proteolysis likely contributes to the increase in kidney protein content and hence to diabetic renal hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025232     DOI: 10.1681/ASN.V481582

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Effect of in vitro glucose and diabetic hyperglycemia on mouse kidney protein synthesis: relevance to diabetic microangiopathy.

Authors:  Silvia Iannello; Paolina Milazzo; Fabio Bordonaro; Francesco Belfiore
Journal:  MedGenMed       Date:  2005-09-07

2.  Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy.

Authors:  Wei Jing Liu; Ting Ting Shen; Rui Hong Chen; Hong-Luan Wu; Yan Jin Wang; Jian Kun Deng; Qiu Hua Chen; Qingjun Pan; Chang-mei Huang Fu; Jing-li Tao; Dong Liang; Hua-feng Liu
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

Review 3.  Chaperone-mediated autophagy in the kidney: the road more traveled.

Authors:  Harold A Franch
Journal:  Semin Nephrol       Date:  2013-11-22       Impact factor: 5.299

Review 4.  Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.

Authors:  Yosuke Hirakawa; Reiko Inagi
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

Review 5.  The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.

Authors:  Pasquale Cocchiaro; Valeria De Pasquale; Rossella Della Morte; Simona Tafuri; Luigi Avallone; Anne Pizard; Anna Moles; Luigi Michele Pavone
Journal:  Front Cell Dev Biol       Date:  2017-12-19

6.  Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury.

Authors:  Sreenithya Ravindran; Mazhar Pasha; Abdelali Agouni; Shankar Munusamy
Journal:  Biomolecules       Date:  2019-08-06

Review 7.  Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease.

Authors:  Man Wu; Minjie Zhang; Yaozhi Zhang; Zixian Li; Xingyu Li; Zejian Liu; Huafeng Liu; Xiaoyu Li
Journal:  Cell Death Dis       Date:  2021-10-18       Impact factor: 8.469

8.  Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease.

Authors:  Christopher Fox; Pasquale Cocchiaro; Fiona Oakley; Rachel Howarth; Krystena Callaghan; Jack Leslie; Saimir Luli; Katrina M Wood; Federica Genovese; Neil S Sheerin; Anna Moles
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.